These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31691981)

  • 1. Atrial fibrillation-related stroke in women: Evidence and inequalities in epidemiology, mechanisms, clinical presentation, and management.
    Kostopoulou A; Zeljko HM; Bogossian H; Ciudin R; Costa F; Heijman J; Kochhaeuser S; Manola S; Scherr D; Sohal M; Wakili R; Wolf M; Irfan G;
    Clin Cardiol; 2020 Jan; 43(1):14-23. PubMed ID: 31691981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.
    Subramanya V; Claxton JS; Lutsey PL; MacLehose RF; Chen LY; Chamberlain AM; Norby FL; Alonso A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):598. PubMed ID: 34915858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program.
    Mazurek M; Huisman MV; Rothman KJ; Paquette M; Teutsch C; Diener HC; Dubner SJ; Halperin JL; Zint K; França LR; Lu S; Lip GYH;
    Am J Med; 2018 Aug; 131(8):945-955.e3. PubMed ID: 29654720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: stroke prevention in focus.
    Ferguson C; Inglis SC; Newton PJ; Middleton S; Macdonald PS; Davidson PM
    Aust Crit Care; 2014 May; 27(2):92-8. PubMed ID: 24054541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Management and Outcomes in Men and Women With Nonvalvular Atrial Fibrillation: Data From a Population-Based Cohort.
    Arnson Y; Hoshen M; Berliner Senderey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    JACC Clin Electrophysiol; 2018 May; 4(5):604-614. PubMed ID: 29798787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
    Marzona I; Proietti M; Farcomeni A; Romiti GF; Romanazzi I; Raparelli V; Basili S; Lip GYH; Nobili A; Roncaglioni MC
    Int J Cardiol; 2018 Oct; 269():182-191. PubMed ID: 30025657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants.
    Pancholy SB; Sharma PS; Pancholy DS; Patel TM; Callans DJ; Marchlinski FE
    Am J Cardiol; 2014 Feb; 113(3):485-90. PubMed ID: 24315113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation.
    Lee H; Tan MK; Yan AT; Angaran P; Dorian P; Bucci C; Gregoire JC; Bell AD; Green MS; Gross PL; Skanes A; Kerr CR; Mitchell LB; Cox JL; Essebag V; Heilbron B; Ramanathan K; Fournier C; Wheeler BH; Lin PJ; Berall M; Langer A; Goldin L; Goodman SG;
    Can J Cardiol; 2019 Feb; 35(2):160-168. PubMed ID: 30760422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
    Skanes AC; Healey JS; Cairns JA; Dorian P; Gillis AM; McMurtry MS; Mitchell LB; Verma A; Nattel S;
    Can J Cardiol; 2012; 28(2):125-36. PubMed ID: 22433576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex.
    Pilcher SM; Alamneh EA; Chalmers L; Bereznicki LR
    Ann Pharmacother; 2020 Sep; 54(9):837-845. PubMed ID: 32019321
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS; Lip GY
    Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.
    Adderley NJ; Ryan R; Nirantharakumar K; Marshall T
    Heart; 2019 Jan; 105(1):27-33. PubMed ID: 29991504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.